Catalyst Pharmaceuticals, Inc. (CPRX) Latest Stock News
Get the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock news and headlines to help you in your trading and investing decisions.
CPRX Stock Rises 17% on Settling Firdapse Patent Litigation With …
1 day ago · The drug is the primary top-line driver for CPRX, accounting for 65% of the company’s net product sales in 2023. In the first nine months of 2024, Firdapse sales generated $223.5 million in ...
Catalyst stock climbs 15% on Firdapse litigation settlement - MSN
Catalyst Pharmaceuticals (NASDAQ:CPRX) stock jumped 15% Wednesday on news the company had reached an agreement with Teva (TEVA) that would delay the launch of a generic version of its drug ...
Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?
1 day ago · Catalyst (CPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Catalyst Pharmaceuticals Secures Patent Victory ... - Markets Insider
3 days ago · Citi analyst Samantha Semenkow has maintained their bullish stance on CPRX stock, giving a Buy rating today. Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter ...
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE ...
2 days ago · CORAL GABLES, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing ...
Catalyst Pharmaceuticals up 18% after resumption following Teva ...
2 days ago · Shares of Catalyst Pharmaceuticals (CPRX) have resumed trading and are higher after the company announced that the company and its licensor SERB S.A. have entered into a settlement agreement with ...
CPRX Stock Price | Catalyst Pharmaceuticals Inc. Stock Quote …
4 days ago · CPRX | Complete Catalyst Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Catalyst Pharmaceuticals, Inc. (CPRX) - Stock Analysis
4 days ago · Get a real-time Catalyst Pharmaceuticals, Inc. (CPRX) stock price quote with breaking news, financials, statistics, charts and more.
Catalyst stock climbs 15% on Firdapse litigation settlement
2 days ago · Catalyst (CPRX) stock jumped 15% on news the company had reached an agreement with Teva (TEVA) that would delay the launch of a generic version of Firdapse until at least 2035.